Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study
Summary We evaluated how romosozumab affects bone structure, density, and strength at the wrist over 12 months. Volumetric bone mineral density did not increase, but high-resolution quantitative computed tomography imaging showed modest improvements in bone strength. These…